Pills to treat COVID-19 will be game-changers, but the best strategy remains prevention

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 73 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 32%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

OPINION: The Pfizer and Merck pills will only be useful if people have access to cheap, fast and accurate testing.

Nearly two years into the pandemic, it has become starkly clear that we need better treatments for COVID-19 for people in the earlier stages of disease.

As an infectious diseases physician and scientist at the University of Virginia, I have helped care for hundreds of people with COVID-19. I’ve also helped conduct clinical trials to find new treatments. Molnupiravir and Paxlovid would fill a need that hasn’t been met by other COVID-19 drugs, which are either difficult to administer or only suitable for patients in the hospital.

Early data suggests that both molnupiravir and Paxlovid are effective new drugs that patients can take at home to prevent complications of COVID-19 – which could be particularly beneficial for those at high risk of severe disease. Once authorized, these pills will allow patients to be treated earlier in the course of infection, at the point when antiviral drugs are more effective.

Molnupiravir and Paxlovid were studied in separate clinical trials with similar designs. In both studies, the drugs were tested in outpatients with risk factors for severe COVID-19 who were at an early stage in their illness. Both studies also looked at how likely patients were to either die or be hospitalized. However, neither study has yet been peer-reviewed.

If and when these drugs get authorized in the U.S., they will probably be used for the same higher-risk patients who are eligible for monoclonal antibodies today. Monoclonal antibodies may still be used, though, for pregnant people, people on dialysis and some immune-compromised patients.

Source: Healthcare Press (healthcarepress.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

And if they look less like a nuclear hot dog

I don’t agree at all. The symptoms are pretty clear, high fever and loss of taste or smell. Have 24-48 hours and can take steroid inhalers or saline sprays. Don’t forget that an aspirin reduces chance of infection by 50%. Vit D really helps as well. Others but test good

ah look they have a pill for the common cold

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Dr. Patel on vaccine boosters, Pfizer Covid pill'Vaccines are still the best protection, but if we see breakthrough infections...these pills can be more of a tool instead of waiting until people end up in an emergency room or a hospital,' Dr. Kavita Patel says about the Pfizer Covid-19 pill. Except the pills haven't been tested on the vaccinated yet. Trials were only done on unvaccinated. The 2 pills that included vaccinated failed their trials. JoeBiden campaigned on ending COVID and curing cancer. Since his election, 540,000 more deaths in US, or 120000 more than when Trump left office. I guess sleepy Joe promised more than he could deliver 😳
Source: MSNBC - 🏆 469. / 51 Read more »

Plaintiffs' lawyers get $115 mln in fees in Pfizer EpiPen dealA federal judge on Wednesday signed off on Pfizer Inc's $345 million settlement resolving claims by consumers who say they overpaid for the emergency allergy treatment EpiPen, and awarded plaintiffs' firms including Robbins Geller Rudman & Dowd and Keller Rohrback $115 million in fees. It would still be better than no one dares to challenges that big firms.
Source: Reuters - 🏆 2. / 97 Read more »

BMO initiates Pfizer at outperform, says Covid drugs and strong pipeline will boost pharma stockNew for subscribers: BMO initiates Pfizer at outperform, says Covid drugs and strong pipeline will boost pharma stock. Check out CNBCPro today. Pro COVID19vaccines: Where are we nowČervený ornamentální otazník 3️⃣ Rolling reviews in progress, 1️⃣ new application submitted for a conditional marketing authorisation, 4️⃣ authorisations completed. $NVAX nvax Covid19 PublicHealthEmergency Pandemic Pro COVID19vaccines 3️⃣ Rolling reviews in progress, 1️⃣ new application submitted for a conditional marketing authorisation, 4️⃣ authorisations completed. $NVAX NVAX Novavax Covid19 PublicHealthEmergency Pandemic
Source: CNBC - 🏆 12. / 72 Read more »

FDA authorizes Pfizer, Moderna boosters for all adults, sending process to CDC for last stepsBREAKING: The FDA has authorized booster doses of the Pfizer-BioNTech and Moderna COVID-19 vaccines for everyone 18 and older who is already considered fully vaccinated. They can give it to themselves and their family, didn’t the FDA just asked a federal judged to alt the release of the data to the public. They want to release it in 56 years from now. They can go to hell with their booster I'd say we are about three months away from my two shots being counted as zero.
Source: ABC - 🏆 471. / 51 Read more »

FDA authorizes Pfizer and Moderna boosters for all adultsBREAKING: FDA authorizes Pfizer and Moderna's Covid-19 boosters for all adults, a move that will make boosters available to everyone ages 18 and up.
Source: NBCNews - 🏆 10. / 86 Read more »

FDA OKs Pfizer, Moderna COVID-19 booster shot for all adultsInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know. CancelBusinessInsider BlodgetTheBilk ThankYouKirk VLS KMS FDA刚刚授权2019冠状病毒疾病疫苗的成人注射疫苗。 Hum! here is my book a Thanksgiving Gift to all of you. This book is my precious Memories with America from 1884. Buy it from me here US $ 45. & $ 50. out of the USA, get a signed copy+ MP3 & MP4 of my prayer song for America+PM3 & MP4 of my Christmas film
Source: BusinessInsider - 🏆 729. / 51 Read more »